CN Chen
Director at Oberland Capital
New York City, New York
CN Chen, Director at Oberland Capital is an active investor based in New York City, New York. This profile covers what CN Chen backs, at which stage, and how founders can reach out in 2026.
- Investor type
- VCVenture Debt
- Stages
- SeedSeries ASeries BLate Stage Venture
- Invests in
- Healthcare & BiotechBiotech & PharmaMedTech & Medical Devices
- Location
- New York City, New York
- Typical check
- $2M
- Past investments
- 5
Notable investments
Mirum Pharmaceuticals
Impact BiomedicinesWindsor Owners Corp.
NorthStar Medical Radioisotopes
Primmune TherapeuticsHow to reach CN Chen
Angels and operators like CN Chen reply to specific, personalized notes that show real traction, not mass blasts. Build a verified list, write a note that fits their thesis, and track replies, all on Round Funded Accelerator.
Connect with CN Chen
Frequently Asked Questions
What does CN Chen invest in?
CN Chen invests in Healthcare & Biotech, Biotech & Pharma and MedTech & Medical Devices, typically at Seed, Series A, Series B and Late Stage Venture. Match your sector and stage, then reach out with a personalized pitch.
What stage does CN Chen invest at?
CN Chen typically invests at Seed, Series A, Series B and Late Stage Venture. Lead with traction that fits the stage when you reach out.
What is CN Chen's typical check size?
CN Chen typically writes checks around $2M. Use it as a signal for whether your raise fits their stage.
How do I contact CN Chen?
Unlock CN Chen's verified email on Round Funded Accelerator and send a personalized pitch. We surface only deliverable contacts so your outreach lands.